General Cancer News
Top Stories
New Genetic Techniques To Combat Lung Cancer
POSTED: May 2, 2008New results on genetic techniques that are helping doctors diagnose and treat lung cancer were released at the 1st European Lung Cancer Conference jointly organized by the European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC) in Geneva, Switzerland. In one report (Abstract No. 81O; Friday ...
Mutation Database Helps Personalized Treatment Of Lung Cancer
POSTED: May 2, 2008A groundbreaking free tool to help oncologists choose the best therapies for patients with non-small-cell lung cancer has been launched this week by scientists at the 1st European Lung Cancer Conference jointly organized by the European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC) in Geneva, ...
Analysis Shows Combining Sorafenib With Carboplatin/paclitaxel Adds No Benefit In Lung Cancer
POSTED: May 2, 2008A clinical trial evaluating the benefit of adding the drug sorafenib to the combination of carboplatin/paclitaxel chemotherapy for lung cancer patients has been stopped based on results from an interim analysis, after an independent data monitoring committee concluded that the study would not meet its primary endpoint of improved overall survival. In a ...
Viruses May Play A Role In Lung Cancer Development
POSTED: May 2, 2008Papers presented at the 1st European Lung Cancer Conference, jointly organized by the European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC) in Geneva, Switzerland highlight emerging evidence that common viruses may contribute to the development of lung cancer. Experts agree that smoking is...
Researchers Discover Novel Approach To Estimate Risk Of Breast Cancer
POSTED: May 2, 2008ROCHESTER, Minn. -- In a paper published today, a team of medical researchers from the Mayo Clinic in collaboration with academic colleagues from Myriad Genetics Laboratories, the University of Utah, France, and Australia report on the outcome of a study that analyzes the risk for breast cancer imparted by inherited mutations in the BRCA2 gene. ...
Digital Mammography A Leap Forward For Women; New Screening Method Faster, More Accurate, Produces Less Radiation
POSTED: May 2, 2008The number of women having breast cancer screenings on a regular basis has declined in recent years, experts agree. New technology may not be enough of an incentive to get women back into the screening rooms. But the director of diagnostic imaging for Lovelace Women's Hospital figures talking about digital mammography just might help raise aw...
Chemo Fails To Root Out Breast Cancer Stem Cells: Study
POSTED: May 2, 2008While chemotherapy can remove breast cancer tumors, it fails to root out the stem cells that can revive the cancer, researchers said in a study published Tuesday. Comparing the challenge to eradicating stubborn weeds from a garden, the researchers at Baylor College of Medicine (BCM) in Houston, Texas, said chemotherapy often fails because it leaves b...
Studies Point To Benefits Of Personalized Chemotherapy Dose Management In Colorectal Cancer
POSTED: May 2, 2008BETHLEHEM, Pa. -- Can a blood test improve treatment outcomes for colorectal cancer patients? Recently published studies indicate that personalized chemotherapy dose management -- measuring drug levels in patients' blood and adjusting them for optimal dosing -- can substantially reduce severe toxicity and improve efficacy in colorectal cancer. ...
ACORN Presents Findings Of Collaborative Metastatic Colorectal Cancer Research
POSTED: May 2, 2008On Tuesday, April 15th, Lee S. Schwartzberg, MD, FACP, President of the Accelerated Community Oncology Research Network, Inc. presented findings at the American Association for Cancer Research annual meeting in San Diego. The Phase II study tested a novel biologic agent in conjunction with chemotherapy used in colorectal cancer with encouraging interim ...
When To Wait And When To Treat? New Program Will Search For Biomarkers In Men With Prostate Cancer To Help Find An Answer
POSTED: May 2, 2008SEATTLE -- Researchers at Fred Hutchinson Cancer Research Center have a lead role in a new public/private partnership to create the first systematic surveillance program of men with prostate cancer to look for biological clues to help determine when to wait and when to treat the disease. The project was announced by the Canary Foundation and the...
